Catalyst Management Team
Steven R. Miller, PhD
Chief Operating Officer and Chief Scientific Officer
Steven R. Miller, PhD, is responsible for Catalyst’s product development program, which includes all aspects of chemistry and manufacturing controls, quality systems, contract operations, and development planning. He was responsible for identifying and in-licensing CPP-115, Catalyst's newest drug candidate, and in taking that product through an initial series of successful non-clinical studies. Dr. Miller has 25 years of experience in the pharmaceutical and healthcare industry. He served as Executive Director for Research and Development Operations for Watson Pharmaceuticals and previously as Vice President of Research and Product Development of Royce Laboratories. Dr. Miller also managed medical device development groups at Baxter Diagnostics and worked as an analytical chemist for the U.S. Food and Drug Administration. Dr. Miller received his doctorate in synthetic organic chemistry at the University of Miami, and his work has been published in numerous technical and professional journals including Journal of Analytical Chemistry, Journal of the American Chemical Society, and Chemical Communications.
Management
- Patrick J. McEnany – Co-Founder, Chairman, President and Chief Executive Officer
- Charles W. Gorodetzky, MD, PhD – Chief Medical Officer
- Alicia Grande, CPA, CMA – Vice President, Chief Financial Officer and Treasurer
- Steven R. Miller, PhD – Chief Operating Officer and Chief Scientific Officer
- Richard P. Rieger – Vice President, Commercial Operations
- M. Douglas Winship – Vice President of Regulatory Operations